GenesyzeResource HubThe desired future state of Real World Evidence Generation for guiding new treatments
The desired future state of Real World Evidence Generation for guiding new treatments
Galson & Simon (2016) describe a desired future state of RWE generation to include:- addressing the needs of real world stakeholders, incentives to improve RWE research, consensus from payers regarding the role of RWE, guidance from regulatory bodies, more flexible boundaries between premarket and postmarket research, and improved public health from more widely shared real world data.
(Galson and Simon, 2016) ‘Real-World Evidence to Guide the Approval and Use of New Treatments’, Discussion Article
REACH OUT TODAY
Arrange a call back...
STAY TUNED IN
Join our global discovery platform. Opt to receive alerts on podcasts, events and other online networking opportunities.
Sign Up Today
We take your privacy very seriously. Your information is never shared for any reason.
Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.
Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out. #theTOMs supporting Kidscan charity
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.
CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse